Viking Therapeutics, Inc. (VKTX) closed at $29.73 in the latest trading session, marking a +0.61% move from the prior day. The stock exceeded the S&P 500, which registered a loss of 0.91% for the ...

Analysts, who are highly bullish on the stock, have fretted for some time that Viking needed a partner to actually make the product, assuming it gains regulatory approval. Viking ...

Researchers at Vrak – Museum of Wrecks, in Stockholm, hope to get funds to excavate a 15th-century shipwreck from the waters ...

The Fall-Winter 2025 shows had infectious energy and eye-catching looks seen both on and off the runways. Beyond Jackson, ...

After a long period of development and having the release pushed back a couple of times, Odinfall will arrive in Early Access ...

Viking clears Q4 views, provides an update on cruise bookings. Shares ease as travel stocks fall on demand warnings. Viking Holdings shares dropped Tuesday as executives warned of macroeconomic ...

Odinfall is a Viking-themed, rogue-lite, twin-stick shooter where you blast your way through procedurally generated levels, upgrade your character, modify your weapons and take down robotic Norse gods ...

Viking has found a manufacturing partner ... Roche takes big step in weight-loss field with $5.3 billion deal. Novo Nordisk shares fall. -Ciara Linnane This content was created by MarketWatch ...